CRIS Current Research Information System

GENTILUCCI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.461
AS - Asia 8.145
EU - Europa 7.216
AF - Africa 668
SA - Sud America 371
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
Totale 24.887
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.364
CN - Cina 2.424
IT - Italia 2.315
SG - Singapore 2.111
VN - Vietnam 1.967
GB - Regno Unito 1.458
DE - Germania 801
HK - Hong Kong 559
FR - Francia 475
SE - Svezia 385
UA - Ucraina 379
RU - Federazione Russa 340
IN - India 338
IE - Irlanda 264
BR - Brasile 244
TG - Togo 203
NL - Olanda 201
CI - Costa d'Avorio 187
JP - Giappone 157
KR - Corea 148
FI - Finlandia 143
ZA - Sudafrica 121
SC - Seychelles 91
BG - Bulgaria 90
EE - Estonia 88
JO - Giordania 67
CA - Canada 60
CH - Svizzera 58
PH - Filippine 57
AR - Argentina 45
ID - Indonesia 45
TH - Thailandia 41
BE - Belgio 39
ES - Italia 36
EC - Ecuador 29
TW - Taiwan 29
HR - Croazia 28
IQ - Iraq 27
NG - Nigeria 26
MX - Messico 25
PK - Pakistan 25
BD - Bangladesh 24
TR - Turchia 23
AT - Austria 20
PL - Polonia 20
IR - Iran 19
AU - Australia 17
CL - Cile 17
LB - Libano 17
CO - Colombia 16
RO - Romania 15
UZ - Uzbekistan 12
PT - Portogallo 11
GR - Grecia 10
SA - Arabia Saudita 9
LT - Lituania 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
EU - Europa 6
IL - Israele 6
PE - Perù 6
TN - Tunisia 6
VE - Venezuela 6
KZ - Kazakistan 5
PY - Paraguay 5
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
HU - Ungheria 4
NP - Nepal 4
RS - Serbia 4
SI - Slovenia 4
AO - Angola 3
BH - Bahrain 3
JM - Giamaica 3
KE - Kenya 3
MY - Malesia 3
NO - Norvegia 3
AL - Albania 2
BN - Brunei Darussalam 2
BZ - Belize 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
LV - Lettonia 2
ML - Mali 2
NZ - Nuova Zelanda 2
OM - Oman 2
SN - Senegal 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
DM - Dominica 1
Totale 24.870
Salva come PNG Salva come JPEG
Città #
Singapore 1.426
Southend 1.236
Ashburn 828
Fairfield 767
Chandler 597
Santa Clara 526
Bologna 507
Hong Kong 497
San Jose 482
Ho Chi Minh City 436
Hanoi 381
Woodbridge 375
Seattle 346
Wilmington 340
Hefei 335
Beijing 302
Princeton 298
Houston 289
Cambridge 285
Ann Arbor 264
Dong Ket 264
Jacksonville 264
Dublin 245
Lomé 203
Abidjan 187
Boardman 185
Lauterbourg 154
Milan 154
Nanjing 153
Tokyo 133
Padova 130
Westminster 130
Los Angeles 122
Seoul 121
Helsinki 116
Berlin 103
Dallas 102
Sofia 90
Jinan 85
Council Bluffs 81
Shanghai 75
Guangzhou 73
Shenyang 69
Buffalo 68
Da Nang 68
Amman 67
New York 67
Haiphong 65
Saint Petersburg 64
Bremen 61
Frankfurt am Main 58
Rome 58
Tianjin 55
Changsha 54
Hebei 50
Turin 49
Medford 48
Redondo Beach 47
Mülheim 46
San Diego 45
Zhengzhou 44
Redmond 40
Hangzhou 39
Nanchang 38
Brussels 36
Munich 36
Chicago 32
Haikou 31
Wuhan 31
Des Moines 29
São Paulo 28
Bengaluru 27
Jakarta 27
Mountain View 26
Biên Hòa 25
Falkenstein 25
Mahé 25
Phoenix 25
Shenzhen 25
Yubileyny 25
Abeokuta 24
Cesena 24
Orem 24
Redwood City 24
Bari 23
Forlì 23
Toronto 22
Jiaxing 21
The Dalles 21
Atlanta 20
Florence 20
Modena 20
Verona 19
Genoa 18
Kunming 18
Ningbo 18
Norwalk 18
Zurich 18
Amsterdam 17
Chengdu 17
Totale 15.749
Salva come PNG Salva come JPEG
Nome #
Inibitori dei processi infiammatori cronici connessi allo sviluppo di tumori (Inhibitors of the chronic inflammatory processes connected to tumor development) 764
Targeting integrins αvβ3 and α5β1 with new β-lactam derivatives 292
Modern tools for the chemical ligation and synthesis of modified peptides and proteins 275
Synthesis and Biological Evaluation of Nonpeptide alpha-v-beta-3/alpha-5-beta-1 Integrin Dual Antagonists containing 5,6-Dihydropyridin-2-one Scaffolds 268
Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration 268
Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel κ-Opioid Receptor Selective Partial Agonist 264
Dehydro-beta-proline Containing Alpha-4-beta-1 Integrin Antagonists: Stereochemical Recognition in Ligand-Receptor Interplay 263
Thixotropic peptide-based physical hydrogels applied to three-dimensional cell culture 244
Could Dissecting the Molecular Framework of β-Lactam Integrin Ligands Enhance Selectivity? 242
A novel family of minimal PMRI cyclic peptides as versatile scaffolds for generating new molecular topology. 235
Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization 234
Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects 232
5-aminomethyloxazolidine-2,4-dione hybrid α/β-dipeptide scaffolds as inductors of constrained conformations: Applications to the synthesis of integrin antagonists 232
A convenient synthesis of functionalized isoxazolines and related 5-hydroxy-isoxazolidine-4-carboxylates 221
Preparation of Non-Toxic Fluorescent Peptide-Coated Silica/PEG Nanoparticles from Peptide-Block Copolymer Conjugates 219
A simple route towards peptide analogues containing substituted (S)- or (R)-tryptophans 217
DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs 217
Conjecturing about Small-Molecule Agonists and Antagonists of α4β1 Integrin: From Mechanistic Insight to Potential Therapeutic Applications 214
Practical synthesis of 3-bromo-5,6-dihydropyridin-2-ones via β,γ-unsaturated α-bromo-ketene/imine cycloaddition 210
alpha-Bromo-beta,gamma-unsaturated Ketenes as Valuable Intermediates in the Synthesis of alpha-Amino-beta,gamma-Unsaturated Acids 207
Integrin-targeting dye-doped peg-shell/silica-core nanoparticles mimicking the proapoptotic Smac/DIABLO protein 207
Synthesis and Antiproliferative Activity against Cancer Cells of Indole-Aryl-Amide Derivatives 205
Diagnostic implementation of fast and selective integrin-mediated adhesion of cancer cells on functionalized zeolite L monolayers 205
A novel family of minimalist opioid peptides deprived of the classic pharmacophores 203
A microwave-enhanced, Lewis acid-catalyzed synthesis of 1,3-dioxolanes and oxazolines from epoxides 203
Highly Regio- and Diastereoselective Palladium-Catalyzed Allylic Substitution. Synthesis of 3-(2-aminobutylidene)-4-arylazetidin-2-ones 202
Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist 201
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 199
Green synthesis of bioactive oligopeptides promoted by recyclable nanocrystalline hydroxyapatite 199
Integrin Ligands with α/β-Hybrid Peptide Structure: Design, Bioactivity, and Conformational Aspects 198
Antiangiogenic Effect of Dual/Selective α5β1/αvβ3 Integrin Antagonists Designed on Partially Modified Retro-Inverso Cyclotetrapeptide Mimetics 197
Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation 195
Controlling Cyclopeptide Backbone Conformation with β/α-Hybrid Peptide–Heterocycle Scaffolds 194
Peptide bond formation using unprotected N-carboxyanhydrides under green chemistry conditions 194
Ac-D-Trp-PheNH2 AND Ac-D-Trp-Phe-GlyNH2 - A NEW CLASS OF UNUSUAL OPIOID PEPTIDES 193
Zinc Metal-Promoted Nucleophilic Addition of Azetidin-2-ones to Aldehydes and Nitriles 191
Design of α/β-hybrid peptide ligands of α4β1 integrin equipped with a linkable side chain for chemoselective biofunctionalization of microstructured materials 191
A straightforward route to enantiopure 2-substituted-3,4-dehydro-beta-proline via ring closing metathesis 190
Exploring the reactivity of alkylidene malonamides: synthesis of polyfunctionalized isoxazolidinones, aziridines and oxazolines 190
An improved microwave assisted protocol for Yonemitsu-type trimolecular condensation 187
Asymmetric Synthesis of three and four membered ring heterocycles 186
An investigation of the reactivity of MCPBA and alpha-bromoalkenes under traditional or microwave-assisted conditions: Selective formation of epoxides or allylic bromides. 186
New trends in the development of opioid peptide analogues as advanced remedies for pain relief 184
Synthesis and evaluation of the affinity toward mu-opioid receptor of atypical, lipophilic ligands based on the sequence c[Tyr-Pro-Trp-Phe-Gly-]. 184
Synthesis and Biological Evaluation of Azido- and Aziridino-hydroxyl-beta -lactams through Stereo- and Regioselective Epoxide Ring Opening. 182
Convenient Synthesis of the Antibiotic Linezolid via an Oxazolidine-2,4-dione Intermediate Derived from the Chiral Building Block Isoserine 182
Synthesis and assay of retro-α4β1 integrin-targeting motifs 181
Topological exploration of cyclic endomorphin-1 analogues, structurally defined models for investigating the bioactive conformation of MOR agonists. 179
Investigation of the Interaction Between the Atypical Agonist c[YpwFG] and MOR 179
DESIGN AND SYNTHESIS OF OPIOID PEPTIDE ANALOGUES AND MIMETICS 179
Modulation of αvβ3- and α5β1-integrin-mediated adhesion by dehydro-β-amino acids containing peptidomimetics 179
PacDOCK: A Web Server for Positional Distance-Based and Interaction-Based Analysis of Docking Results 177
Asymmetric Synthesis of Three and Four Membered Ring Heterocycles - Chapter 1 176
The Inverse Type II β-Turn on D-Trp-Phe, a Pharmacophoric Motif for MOR Agonists. 176
Dehydro-beta-amino Acid Containing Peptides as Promising Sequences for Drug Development 173
Opioid Activity Profiles of Oversimplified Peptides Lacking in the Protonable N-Terminus 171
In-peptide synthesis of di-oxazolidinone and dehydroamino acid-oxazolidinone motifs as β-turn inducers 169
Controlled solid phase peptide bond formation using N-carboxyanhydrides and PEG resins in water. 168
Highly Diastereoselective Allylic Azide Formation and Isomerization. Synthesis of 3(2'-Amino)-beta-lactams 167
Peptides inhibiting the assembly of monomeric human l‐lactate dehydrogenase into catalytically active homotetramer decrease the synthesis of lactate in cultured cells 166
Highly regio- and stereoselective palladium-catalyzed allylic carbonate amination. A practical route to dehydro-beta-amino esters 166
Unusual Amino Acids: Synthesis and Introduction into Naturally Occurring Peptides and Biologically Active Analogues 165
Cyclotetrapeptide Mimics based on a 13-Membered, Partially Modified Retro-Inverso Structure 165
Expedient recycling of peptide organocatalysts using a nanocrystalline hydroxyapatite catching system 164
NEW PEPTIDOMIMETIC α4β1-INTEGRIN ANTAGONISTS FOR REDUCING INFLAMMATION AND ALLERGIC REACTIONS 163
Identification of c[D-Trp-Phe-β-Ala-β-Ala], the First κ-Opioid Receptor-Specific Negative Allosteric Modulator 162
A new generation of opioid peptidomimetics acting as central and/or peripheral analgesics 162
Peptides and peptidomimetics in medicine, surgery, and biotecnology 161
Inhibition of cancer cell adhesion by heterochiral Pro-containing RGD mimetics. 161
Lewis acid induced highly regioselective synthesis of a new class of substituted isoxazolidines 161
Enzymatic Resolution of Ethyl 3-Hydroxy-2(1'substituted-methylidene)-butyrate by Pseudomonas Cepacia Lipase Catalyzed Acetylation 161
Cyclopeptide analogs for generating new molecular and 3D diversity 160
Functionalizations of the C3 side chain of densely substituted azetidin-2-ones 159
Introduction of hydroxyl- or keto- functionalities into the side chain of azetidin-2-ones via allylic bromide rearrangement, followed by supported reagent substitution 159
Synthesis of dehydro-beta-amino esters via highly regioselective amination of allylic carbonates 158
Heterocyclic Scaffolds in the Design of Peptidomimetic Integrin Ligands: Synthetic Strategies, Structural Aspects, and Biological Activity 158
Synthesis and Conformational Analysis of Cyclotetrapeptide Mimetic beta-Turn Templates and Validation as 3D Scaffolds 158
Selective detection of α4β1 integrin (VLA-4)-expressing cells using peptide-functionalized nanostructured materials mimicking endothelial surfaces adjacent to inflammatory sites 158
Peptide direct growth on poly(acrylic acid)/poly(vinyl alcohol) electrospun fibers coated with branched poly(ethylenimine): A solid-phase approach for scaffolds biofunctionalization 156
Development of isoxazoline-containing peptidomimetics as dual alpha-v-beta-3 and alpha-5-beta-1 integrin ligands. 156
Cyclic side-chain-linked opioid analogs utilizing cis- and trans-4-aminocyclohexyl-d-alanine 156
Purification from Deinococcus radiodurans of a 66 kDa ABC transporter acting on peptides containing at least 3 amino acids 156
Design, Pharmacological Characterization, and Molecular Docking of Minimalist Peptidomimetic Antagonists of α4β1 Integrin 155
Stereoselective synthesis of a new class of spiro-beta-lactams via epoxide ring opening 155
One-Pot Synthesis of Poly-Substituted Tetramic Acids for the Preparation of Reverse-Turn Mimics 155
Versatile Picklocks to Access All Opioid Receptors: Tuning the Selectivity and Functional Profile of the Cyclotetrapeptide c[Phe- d -Pro-Phe-Trp] (CJ-15,208) 152
Molecular Docking of Opiates and Opioid Peptides, a Tool for the Design of Selective Agonists and Antagonists, and for the Investigation of Atypical Ligand-Receptor Interactions 152
Synthesis of chiral non-racemic intermediates and Arg-Gly-Asp mimetics by CaLB-catalyzed resolution 151
Design and characterization of opioid ligands based on cycle-in-macrocycle scaffold 151
Stereoselective synthesis of a new class of spiro-beta-lactams via epoxide ring opening 150
Dehydro-beta-amino acids as scaffolds for the preparation of alpha-v-beta-3, alpha-5-beta-1 and alpha-4-beta-1 integrin ligands 149
Synthesis of Ethyl 5-Hydroxyisoxazolidine-4-carboxylates via Michael Addition/Intramolecular Hemiketalisation 149
Design and Pharmacological Characterization of α4β1 Integrin Cyclopeptide Agonists: Computational Investigation of Ligand Determinants for Agonism versus Antagonism 148
Stereoselective Synthesis of Linear and Cyclic Dehydro-beta-amino Acids for the Preparation of alpha-v-beta-3 and alpha-5-beta-1 Integrin Inhibitors 148
Design and synthesis of Alpha-v-beta-3 and Alpha-5-beta-1 integrin ligands as delivery systems for fluorescent molecules 148
DETERMINATION OF THE BIOLOGICALLY ACTIVE STRUCTURE OF THE ATYPICAL MOR-LIGAND c[D-Asp-1-amide-beta-Ala-D-Trp-Phe] AND ANALOGUES BY NMR AND MOLECULAR DOCKING 147
Integrin-targeting peptides for the design of functional cell-responsive biomaterials 147
Synthesis of Enantiomerically Pure alpha-v-beta-3 Integrin ligands Based on a 5,6-Dihydropyridin-2-one Scaffold. 145
Easy preparation of dehydroalanine building blocks equipped with oxazolidin-2-one chiral auxiliaries, and applications to the stereoselective synthesis of substituted tryptophans 143
Linker Hydrophilicity Modulates the Anticancer Activity of RGD–Cryptophycin Conjugates 142
Totale 19.018
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.613
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021691 0 0 0 0 0 0 0 0 0 125 134 432
2021/20222.693 342 154 185 132 261 145 95 292 107 147 409 424
2022/20233.064 262 442 155 379 222 260 119 160 585 90 236 154
2023/20241.371 91 134 80 117 168 283 101 98 43 99 83 74
2024/20254.100 192 591 377 240 760 250 400 118 37 250 133 752
2025/20267.441 632 773 695 596 892 467 946 257 1.690 493 0 0
Totale 25.343